News & Updates
Showing Cardiology articles
Showing
Septal LGE predicts major ventricular arrhythmia, cardiac death in cardiomyopathy
Late gadolinium enhancement (LGE) with septal location is significantly associated with major arrhythmic events among patients with dilated cardiomyopathy (DCM) and nondilated left ventricular (LV) cardiomyopathy (NDLVC), suggests a recent study.
Solo ticagrelor after 1-month DAPT: Is it time to change practice?
Dropping aspirin for ticagrelor monotherapy 1 month after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) is as good as dual antiplatelet therapy (DAPT) in the ULTIMATE-DAPT* trial presented at ACC.24.
GLP-1 RA plus SGLT-2i better than monotherapy for CV, renal events prevention
Patients with type 2 diabetes (T2D) who received combined treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter-2 inhibitors (SGLT-2i) have a much lower risk of major adverse cardiovascular events (MACE) and serious renal events than those treated with either drug class alone, suggests a recent study.
Semaglutide benefits extend to HFpEF patients with T2D
The weight loss and heart failure (HF) benefits of semaglutide extend to patients with obesity-related HF with preserved ejection fraction (HFpEF) and type 2 diabetes (T2D) in the STEP-HFpEF DM trial, fuelling speculation that semaglutide may have cardiovascular effects beyond weight loss.